Literature DB >> 9392925

Intractable nausea and vomiting due to gastrointestinal mucosal metastases relieved by tetrahydrocannabinol (dronabinol).

F Gonzalez-Rosales1, D Walsh.   

Abstract

Four years following resection of a Clark's level IV malignant melanoma, a 50-year-old man developed widespred metastatic disease involving the liver, bones, brain, gastrointestinal mucosa, and lungs. One week after whole brain radiation therapy, he was admitted to the hospital for nausea, vomiting, and pain. He was treated with several antiemetic drugs, but it was not until dronabinol was added that the nausea and vomiting stopped. Dronabinol was an effective antiemetic used in combination with prochlorperazine in nausea and vomiting unresponsive to conventional antiemetics.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9392925     DOI: 10.1016/S0885-3924(97)00229-7

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  14 in total

1.  The novel cannabinoid CB1 receptor neutral antagonist AM4113 suppresses food intake and food-reinforced behavior but does not induce signs of nausea in rats.

Authors:  Kelly S Sink; Peter J McLaughlin; Jodi Anne T Wood; Cara Brown; Pusheng Fan; V Kiran Vemuri; Yan Peng; Yan Pang; Teresa Olszewska; Teresa Olzewska; Ganesh A Thakur; Alex Makriyannis; Linda A Parker; John D Salamone
Journal:  Neuropsychopharmacology       Date:  2007-06-20       Impact factor: 7.853

Review 2.  Cannabinoid CB1 receptor inverse agonists and neutral antagonists: effects on food intake, food-reinforced behavior and food aversions.

Authors:  John D Salamone; Peter J McLaughlin; Kelly Sink; Alexandros Makriyannis; Linda A Parker
Journal:  Physiol Behav       Date:  2007-04-14

3.  Cannabinoids in pain management. Study was bound to conclude that cannabinoids had limited efficacy.

Authors:  E Russo
Journal:  BMJ       Date:  2001-11-24

Review 4.  Nutrition therapy issues in esophageal cancer.

Authors:  Keith R Miller; Matthew C Bozeman
Journal:  Curr Gastroenterol Rep       Date:  2012-08

Review 5.  2016 Updated MASCC/ESMO consensus recommendations: Management of nausea and vomiting in advanced cancer.

Authors:  Declan Walsh; Mellar Davis; Carla Ripamonti; Eduardo Bruera; Andrew Davies; Alex Molassiotis
Journal:  Support Care Cancer       Date:  2016-08-17       Impact factor: 3.603

6.  [Dronabinol for supportive therapy in patients with malignant melanoma and liver metastases].

Authors:  M Zutt; H Hänssle; S Emmert; C Neumann; L Kretschmer
Journal:  Hautarzt       Date:  2006-05       Impact factor: 0.751

Review 7.  Systematic review of the efficacy of antiemetics in the treatment of nausea in patients with far-advanced cancer.

Authors:  Paul Glare; Glenn Pereira; Linda J Kristjanson; Martin Stockler; Martin Tattersall
Journal:  Support Care Cancer       Date:  2004-04-24       Impact factor: 3.603

8.  [Treatment of nausea and vomiting with 5HT3 receptor antagonists, steroids, antihistamines, anticholinergics, somatostatinantagonists, benzodiazepines and cannabinoids in palliative care patients : a systematic review].

Authors:  G Benze; A Geyer; B Alt-Epping; F Nauck
Journal:  Schmerz       Date:  2012-09       Impact factor: 1.107

Review 9.  Anorexia: aetiology, epidemiology and management in older people.

Authors:  David R Thomas
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

Review 10.  Nausea and Vomiting: a Palliative Care Imperative.

Authors:  Rita J Wickham
Journal:  Curr Oncol Rep       Date:  2020-01-20       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.